Joint Corp. (JYNT) closed at $7.37 on October 22, 2026, up 2.8% from the previous close, on volume of 32,772 shares (30-day average 86,205).
Data as of October 22, 2026.
No headlines found.
Globe Newswire (Thu, 22-Oct 7:05 AM ET)
The Joint Chiropractic Expands Growth Opportunities Through Strategic Territory Reacquisition
PRNewswire (Tue, 6-Oct 1:55 PM ET)
The Joint Corp. Reports Second Quarter 2026 Financial Results
Globe Newswire (Thu, 6-Aug 4:05 PM ET)
The Joint Chiropractic Earns Entrepreneur Recognition as a Premier Multi-Unit Franchise Investment
PRNewswire (Thu, 30-Jul 11:00 AM ET)
Globe Newswire (Thu, 23-Jul 4:15 PM ET)
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
Joint Corp. trades on the NASDAQ stock market under the symbol JYNT.
As of October 22, 2026, JYNT stock price climbed to $7.37 with 32,772 million shares trading.
JYNT has a beta of 0.95, meaning it tends to be less sensitive to market movements. JYNT has a correlation of 0.10 to the broad based SPY ETF.
JYNT has a market cap of $104.24 million. This is considered a Micro Cap stock.
Last quarter Joint Corp. reported $15 million in Revenue and $.05 earnings per share. This beat revenue expectation by $582,400 and missed earnings estimates by -$.03.
In the last 3 years, JYNT traded as high as $17.82 and as low as $6.79.
The top ETF exchange traded funds that JYNT belongs to (by Net Assets): VTI, VXF, DFAS, SMLF, DFMC.
JYNT has underperformed the market in the last year with a return of -15.4%, while the SPY ETF gained +14.9%. In the last 3 month period, JYNT fell short of the market, returning -16.3%, while SPY returned +2.3%. However, in the most recent 2 weeks JYNT has outperformed the stock market by returning +2.4%, while SPY returned -1.7%.
JYNT support price is $6.95 and resistance is $7.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that JYNT shares will trade within this expected range on the day.
